Global Direct-to-Consumer Genetic Testing Market - Forecasts, Segmentation, and Opportunity Assessment by Technavio

15:23 EDT 1 Aug 2017 | Businesswire
Technavio Research

According to the latest market study released by Technavio, the global direct-to-consumer (DTC) genetic testing market is expected to grow at a CAGR of almost 12% during the forecast period.

This Smart News Release features multimedia. View the full release here:

Technavio has published a new report on the global direct-to-consumer genetic testing market from 20 ...

Technavio has published a new report on the global direct-to-consumer genetic testing market from 2017-2021. (Graphic: Business Wire)

This research report titled ‘Global DTC genetic testing Market 2017-2021’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes up to date analysis and forecasts for various market segments and all geographical regions.

The global DTC genetic testing market grew due to increasing awareness about whole genomic analysis for the early detection of diseases. The growing incidence of chronic diseases such as breast and colorectal cancer, neurological disorders such as Parkinson’s disease, and other diseases such as sickle cell anemia (SCA) is also driving the growth of the market.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

Technavio’s healthcare and life sciencesresearch analysts categorize the global DTC genetic testing market into the following segments by service. They are:

  • Diagnostic screening
  • Prenatal, newborn screening, and pre-implantation diagnosis
  • Relationship testing

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Diagnostic screening

Diagnostic screening is mostly conducted to evaluate major treatment decisions. Diagnostic testing helps identify genes that are responsible for chronic diseases such as cancer. Diagnostic testing includes hereditary testing and carrier screening, which is usually conducted for DTC genetic testing.

According to Srinivas Sashidhar, a lead in-vitro diagnostics research analyst from Technavio, “Companies are developing various strategies to expand in the market. They are forming partnerships with laboratories that conduct genotyping tests. Genotyping services are mostly performed in reference laboratories, which helps laboratories to increase their profits. For instance, LabCorp provides genotyping service to 23andMe.”

Prenatal, newborn screening, and pre-implantation diagnosis

Fetal testing during pregnancy is conducted to determine whether the fetus is likely to suffer from birth defects due to chromosomal disorders. In such cases, maternal blood tests help determine fetal genetic material. To conduct risk analysis, physicians prefer to observe the genetic condition. Hence, DTC genetic testing is conducted. It helps to identify chromosomes that cause Down syndrome (DNS) and SCA.

“Governments in developed countries such as the US and the UK have developed screening programs for prenatal and newborn screening. For pre-implantation diagnosis, few regulations have been formed to reduce the number of abortions. In the UK, the National Health Service’s Fetal Anomaly Screening Programme helps reduce the number of abortions. For prenatal and newborn screening, the governments of the US and the UK provide preference to DNS, Edward’s syndrome, and Patau syndrome,” adds Srinivas.

Relationship testing

Relationship testing, also known as family deoxyribonucleic acid (DNA) testing, helps determine the relationship between grandparents, mother, father, and siblings. In countries such as Australia, the US, and the UK, relationship testing such as paternity testing can be easily obtained from retail stores or ordered from DTC genetic testing companies or clinical laboratories. However, in few countries such as France and India, people require a legal notice to conduct these tests.

Companies are developing home DNA testing, which is easy to conduct and affordable. Companies such as 23andMe are partnering with retail companies to expand their market reach.

The top vendors highlighted by Technavio’s research analysts in this report are:

  • 23andMe
  • LabCorp
  • Myriad Genetics
  • Quest Diagnostics

Browse Related Reports:

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770


More From BioPortfolio on "Global Direct-to-Consumer Genetic Testing Market - Forecasts, Segmentation, and Opportunity Assessment by Technavio"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...